Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion type Assertion NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_head.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion description "[Relevant to its clinical application, muMAb 4D5 may enhance the sensitivity of p185HER2-overexpressing tumor cells to cisplatin, a chemotherapeutic drug often used in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion evidence source_evidence_literature NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion SIO_000772 1679763 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion wasDerivedFrom befree-20140225 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion wasGeneratedBy ECO_0000203 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.